Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank90
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
37.17%
↑ 209% vs avg
Percentile
P90
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-34.03%
Historical baseline
PeriodValue
Q4 202537.17%
Q3 2025-98.69%
Q2 2025-129.88%
Q1 2025139.14%
Q4 2024-326.06%
Q3 2024-479.01%
Q2 2024136.16%
Q1 2024-100.00%
Q4 2023-173.17%
Q3 20234.65%
Q2 202318.87%
Q1 2023-3.92%
Q4 2022-15.91%
Q3 20226.38%
Q2 202244.05%
Q1 20225.62%
Q4 2021-14.10%
Q3 20211.27%
Q2 2021-6.76%
Q1 202132.11%
Q4 2020-21.11%
Q3 20205.26%
Q2 2020-4.40%
Q1 2020-9.64%
Q4 2019-29.69%
Q3 2019-39.13%
Q2 20190.00%
Q1 20190.00%
Q2 20180.00%
Q1 20180.00%